News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
How ICR researchers are leading the way in breast cancer research
In Breast Cancer Awareness Month, Rose Wu looks at some of the recent research breakthroughs by breast cancer researchers at the ICR
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Cancer trades in sugar for fatty acids in order to spread around the body
Scientists have uncovered a crucial change in cancer cells that allows them to spread around the body – by switching from sugar to fatty acids to fuel their growth.
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment.
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
.png?sfvrsn=e5be7df6_2 "Cell division (green 4.3)")
Cell death triggers keep cancer at bay in healthy cells
Two molecules with the power of life and death over cells also play a key role in protecting the genome and preventing cancer, a major new study reveals.
Scientific achievements of 2018
We've selected a range of discoveries from 2017/18 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
ESMO 2018: Major trial shows targeted drug – palbociclib – extends breast cancer survival
Combining a targeted drug with hormone therapy substantially extends survival for women with advanced breast cancer, a major clinical trial has found.
The ICR responds to the FDA approval of talazoparib for women with BRCA-mutant advanced breast cancer
The ICR strongly welcomes the news that talazoparib (trade name Talzenna) has been approved by the US Food and Drug Administration (FDA) for patients with advanced breast cancer.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
Scientists make important breakthrough in understanding our immune system
Researchers have discovered how a key element of our body’s response to diseases works, answering a long-standing and important question in the field of studies of the immune system.
Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.
Blocking energy production could help treat lung cancer where chemotherapy has limited effect
Targeting an enzyme that helps cells to generate energy could trigger cell death and be a way to treat some forms of lung cancer, even where the effect of chemotherapy is limited.
